El Consejo de Farmacia y Química de la Asociación Médica Americana
Smith, Austin E.
Boletín de la Oficina Sanitaria Panamericana (OSP)
; 23(5): 398-410, mayo 1944.
Artículo en Español | PAHO | ID: pah-36124
Documentos relacionados
Opinion paper: scientific, philosophical and legal consideration of doping in sports.
La Regulación de los medicamentos veterinarios en España
An analytical framework for assessing drug and therapeutics committee structure and work processes in tertiary Brazilian hospitals.
[Approval of drugs by national and European agencies--from the viewpoint of drug approval committee A].
[Modification of the prescribing practice of the physician by decisions of drug committees, specialty groups and consensus conferences].
Getting to grips with the new European Union pharmacovigilance legislation.
Pharmacist perspectives and considerations for implementation of therapeutic oncology biosimilars in practice.
[Ministerial circular of 10 October 1985, intended to improve the safety of anesthetized patients].
[Positive lists/negative lists from the viewpoint of clinical pharmacology].
Potential extension of strict products liability to hospitals: P & T committee liability.